AAM
Augustine Asset Management Portfolio holdings
AUM
$374M
This Quarter Return
+7.1%
1 Year Return
+74.86%
3 Year Return
+218.57%
5 Year Return
+313.82%
10 Year Return
+569.96%
AUM
$204M
AUM Growth
+$204M
(+8.8%)
Cap. Flow
+$4.41M
Cap. Flow
% of AUM
2.16%
Top 10 Holdings %
Top 10 Hldgs %
52.95%
Holding
100
New
12
Increased
27
Reduced
38
Closed
4
Top Buys
Top Sells
| 1 |
IBM
IBM
|
$3.36M |
| 2 |
Western Digital
WDC
|
$3.05M |
| 3 |
SPDR Gold Trust
GLD
|
$2.94M |
| 4 |
iShares Silver Trust
SLV
|
$1.14M |
| 5 |
Sysco
SYY
|
$330K |
Sector Composition
| 1 | Technology | 34.61% |
| 2 | Financials | 15.91% |
| 3 | Healthcare | 12.03% |
| 4 | Consumer Discretionary | 7.85% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $23.5M | 11.53% | 132,503 +119 | +0.1% | +$21.1K |
|
2
Microsoft
MSFT
$3.77T
| $21M | 10.3% | 62,536 +48 | +0.1% | +$16.1K |
|
3
TSMC
TSM
$1.2T
| $15.6M | 7.64% | 129,550 +186 | +0.1% | +$22.4K |
|
4
Aptiv
APTV
$17.3B
| $9.27M | 4.54% | 56,191 +785 | +1% | +$129K |
|
5
ICICI Bank
IBN
$113B
| $8.16M | 4% | 412,295 +5,113 | +1% | +$101K |
|
6
Global Payments
GPN
$21.5B
| $7.23M | 3.54% | 53,444 +13,891 | +35% | +$1.88M |
|
7
Merck
MRK
$210B
| $6.3M | 3.09% | 82,181 +4,875 | +6% | +$374K |
|
8
JPMorgan Chase
JPM
$829B
| $5.97M | 2.92% | 37,686 -229 | -0.6% | -$36.3K |
|
9
Nike
NKE
$114B
| $5.58M | 2.73% | 33,465 +483 | +1% | +$80.5K |
|
10
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$4.5B
| $5.42M | 2.66% | 385,802 +255,288 | +196% | +$3.59M |
|
11
Citigroup
C
$178B
| $5.42M | 2.65% | 89,684 +118 | +0.1% | +$7.13K |
|
|
12
SPDR Gold Trust
GLD
$107B
| $5.11M | 2.5% | 29,893 -17,172 | -36% | -$2.94M |
|
|
RDS.A
13
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $4.89M | 2.39% | 112,580 +32,876 | +41% | +$1.43M |
|
14
TotalEnergies
TTE
$137B
| $4.52M | 2.21% | 91,344 +31,900 | +54% | +$1.58M |
|
15
Ecolab
ECL
$78.6B
| $4.5M | 2.2% | 19,167 +348 | +2% | +$81.6K |
|
16
Gilead Sciences
GILD
$140B
| $4.1M | 2.01% | 56,404 -107 | -0.2% | -$7.77K |
|
17
Medtronic
MDT
$119B
| $4.01M | 1.96% | 38,716 +499 | +1% | +$51.6K |
|
18
Intel
INTC
$107B
| $3.97M | 1.95% | 77,149 +1,036 | +1% | +$53.4K |
|
19
Carlyle Group
CG
$23.4B
| $3.7M | 1.81% | 67,449 +1,417 | +2% | +$77.8K |
|
20
Bristol-Myers Squibb
BMY
$96B
| $3.54M | 1.73% | 56,696 -1,903 | -3% | -$119K |
|
21
CSX Corp
CSX
$60.6B
| $3.3M | 1.62% | 87,787 +1,314 | +2% | +$49.4K |
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $3.14M | 1.54% | 4,976 +41 | +0.8% | +$25.9K |
|
23
Ericsson
ERIC
$26.2B
| $3.04M | 1.49% | 279,893 +66,674 | +31% | +$725K |
|
24
Berkshire Hathaway Class A
BRK.A
$1.09T
| $2.7M | 1.32% | 6 | – | – |
|
|
25
iShares Silver Trust
SLV
$19.6B
| $2.43M | 1.19% | 113,072 -52,935 | -32% | -$1.14M |
|